3 Highest Growth Stocks in the Market Today
I'm constantly scanning the market for stocks that promise hyper growth in the years ahead. One tool that I use to find these high growth companies is Finviz. With that in mind, I recently ran a screen on Finviz searching for the following attributes:
From there, I simply sorted by projected earnings-growth rate over the coming five years. These criteria identified three stocks -- Freeport-McMoRan (NYSE: FCX), Corcept Therapeutics (NASDAQ: CORT), and Penumbra (NYSE: PEN) -- that all are expected to grow EPS in excess of 67% annually over the next five years.
Let's take a closer look at each to see if any could actually be worth buying.
Source: Fool.com
Corcept Therapeutics Inc. Stock
Corcept Therapeutics Inc. is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 36 € shows a slightly positive potential of 16.13% compared to the current price of 31.0 € for Corcept Therapeutics Inc..